Pyrimidine compounds and their use as modulators of chemokine receptor activity
US6958344B2 · kind B2 · utility
7Cited by
10References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 7, 2001 |
| Grant date | Oct 25, 2005 |
| Priority date | — |
| Expiry date | Jul 29, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides certain heterocyclic compounds, processes, and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy; in formula (I), A is a group of formula (a) or (b).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.